Evidence map›Paper›PMID 40879407›Full record

ArticleJournal of Alzheimer's disease : JAD2025

Incidence of dementia among individuals 70 years and older in Norway: A HUNT study.

Inger Molvik, Bjørn Heine Strand, Anne Marie Mork Rokstad, Eivind Aakhus, Stina Aam, Sverre Bergh, Anne Brækhus, Knut Engedal, Linda Gjøra, Grete Kjelvik and 6 more

Abstract read
In one paragraph

Article in Journal of Alzheimer's disease : JAD, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Inger MolvikThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0009-0008-1544-3927
Bjørn Heine StrandThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0000-0003-4385-8886
Anne Marie Mork RokstadThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0000-0002-3713-1229
Eivind AakhusThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Stina AamDepartment of Geriatric Medicine, Clinic of Medicine, St Olavs hospital, Trondheim University Hospital, Trondheim, Norway.ORCID 0000-0002-9116-6991
Sverre BerghThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0000-0001-9593-2967
Anne BrækhusThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Knut EngedalThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Linda GjøraThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Grete KjelvikThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0009-0001-4397-357X
Marte Kvello-AlmeDepartment of Psychiatry, Levanger Hospital, Nord-Trøndelag Hospital Trust, Levanger, Norway.
Gill LivingstonDivision of Psychiatry University College London, London, UK.
Fiona E MatthewsInstitute for Clinical and Applied Health Research, University of Hull, Hull, UK.
Karin PerssonThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.
Håvard Kjesbu SkjellegrindHUNT Research Centre, Department of Public Health and Nursing, Faculty of Medicine and Health Sciences, Norwegian University of Science and Technology, Levanger, Norway.ORCID 0000-0003-3067-0016
Geir SelbækThe Norwegian National Centre for Ageing and Health, Vestfold Hospital Trust, Tønsberg, Norway.ORCID 0000-0001-6511-8219

Funding

Wellcome Trust
6 · The paper itself

Abstract

BackgroundWith increasing population longevity, Alzheimer's disease and dementia have become a health priority, and high-quality incidence estimates are needed.ObjectiveTo provide reliable and precise incidence estimates of dementia applying a population-based sample of individuals aged 70+.MethodsA longitudinal cohort design was used, with baseline assessment in the Norwegian HUNT4 70+ study (2017-19) and at follow-up four years later (2021-23). Age-specific dementia incidence rates, standardized for the Norwegian population, were calculated as the number of new dementia cases per 1000 person-years assuming onset midway between study waves with inverse probability weights based on baseline factors associated with non-participation or death.ResultsAmong 5229 dementia-free individuals at baseline, 749 developed dementia over a 4.2-year period, resulting in a cumulative incidence proportion of 14.3%. At follow-up, 33.8% of new dementia cases showed no baseline cognitive impairment, while the rest had mild cognitive impairment (MCI). Of those with baseline MCI, 25.5% reverted to normal cognition, 48.2% remained MCI, and 26.2% developed dementia. The dementia incidence per 1000 person-years, was 43.9 (95% confidence interval (CI) 40.8, 47.1) (weighted for non-response and standardized to the dementia-free Norwegian population).ConclusionsOur study found higher dementia incidence rates in the 70+ population than hospital records indicate. Most individuals had preceding MCI, with similar numbers reverting to normal cognition as developing dementia. The projected incident dementia cases suggest a near doubling between 2023 and 2050, significantly impacting families and healthcare planning, including early detection and interventions.

Indexed as

DementiaAgedAged, 80 and overCognitive DysfunctionCohort StudiesFemaleHumansIncidenceLongitudinal StudiesMaleNorwayAlzheimer’s diseasedementiaepidemiologyincidencepopulation study

Identifiers

PMID40879407
PMCPMC12678644

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.